Cargando…
In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite
Hydroxyapatite (HA) is an important component of the bone mineral phase. It has been used in several applications, such as bone regenerative medicine, tooth implants, drug delivery and oral care cosmetics. In the present study, three different batches of a commercial nanohydroxyapatite (nHA) materia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145068/ https://www.ncbi.nlm.nih.gov/pubmed/33925076 http://dx.doi.org/10.3390/nano11051152 |
_version_ | 1783697093865504768 |
---|---|
author | Kavasi, Rafaela-Maria Coelho, Catarina C. Platania, Varvara Quadros, Paulo A. Chatzinikolaidou, Maria |
author_facet | Kavasi, Rafaela-Maria Coelho, Catarina C. Platania, Varvara Quadros, Paulo A. Chatzinikolaidou, Maria |
author_sort | Kavasi, Rafaela-Maria |
collection | PubMed |
description | Hydroxyapatite (HA) is an important component of the bone mineral phase. It has been used in several applications, such as bone regenerative medicine, tooth implants, drug delivery and oral care cosmetics. In the present study, three different batches of a commercial nanohydroxyapatite (nHA) material were physicochemically-characterized and biologically-evaluated by means of cytotoxicity and genotoxicity using appropriate cell lines based on well-established guidelines (ISO10993-5 and OECD 487). The nHAs were characterized for their size and morphology by dynamic light scattering (DLS) and transmission electron microscopy (TEM) and were found to have a rod-like shape with an average length of approximately 20 to 40 nm. The nanoparticles were cytocompatible according to ISO 10993-5, and the in vitro micronucleus assay showed no genotoxicity to cells. Internalization by MC3T3-E1 cells was observed by TEM images, with nHA identified only in the cytoplasm and extracellular space. This result also validates the genotoxicity since nHA was not observed in the nucleus. The internalization of nHA by the cells did not seem to affect normal cell behavior, since the results showed good biocompatibility of these nHA nanoparticles. Therefore, this work is a relevant contribution for the safety assessment of this nHA material. |
format | Online Article Text |
id | pubmed-8145068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81450682021-05-26 In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite Kavasi, Rafaela-Maria Coelho, Catarina C. Platania, Varvara Quadros, Paulo A. Chatzinikolaidou, Maria Nanomaterials (Basel) Article Hydroxyapatite (HA) is an important component of the bone mineral phase. It has been used in several applications, such as bone regenerative medicine, tooth implants, drug delivery and oral care cosmetics. In the present study, three different batches of a commercial nanohydroxyapatite (nHA) material were physicochemically-characterized and biologically-evaluated by means of cytotoxicity and genotoxicity using appropriate cell lines based on well-established guidelines (ISO10993-5 and OECD 487). The nHAs were characterized for their size and morphology by dynamic light scattering (DLS) and transmission electron microscopy (TEM) and were found to have a rod-like shape with an average length of approximately 20 to 40 nm. The nanoparticles were cytocompatible according to ISO 10993-5, and the in vitro micronucleus assay showed no genotoxicity to cells. Internalization by MC3T3-E1 cells was observed by TEM images, with nHA identified only in the cytoplasm and extracellular space. This result also validates the genotoxicity since nHA was not observed in the nucleus. The internalization of nHA by the cells did not seem to affect normal cell behavior, since the results showed good biocompatibility of these nHA nanoparticles. Therefore, this work is a relevant contribution for the safety assessment of this nHA material. MDPI 2021-04-28 /pmc/articles/PMC8145068/ /pubmed/33925076 http://dx.doi.org/10.3390/nano11051152 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kavasi, Rafaela-Maria Coelho, Catarina C. Platania, Varvara Quadros, Paulo A. Chatzinikolaidou, Maria In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite |
title | In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite |
title_full | In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite |
title_fullStr | In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite |
title_full_unstemmed | In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite |
title_short | In Vitro Biocompatibility Assessment of Nano-Hydroxyapatite |
title_sort | in vitro biocompatibility assessment of nano-hydroxyapatite |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145068/ https://www.ncbi.nlm.nih.gov/pubmed/33925076 http://dx.doi.org/10.3390/nano11051152 |
work_keys_str_mv | AT kavasirafaelamaria invitrobiocompatibilityassessmentofnanohydroxyapatite AT coelhocatarinac invitrobiocompatibilityassessmentofnanohydroxyapatite AT plataniavarvara invitrobiocompatibilityassessmentofnanohydroxyapatite AT quadrospauloa invitrobiocompatibilityassessmentofnanohydroxyapatite AT chatzinikolaidoumaria invitrobiocompatibilityassessmentofnanohydroxyapatite |